Gainers
- Superconductor Technologies Inc. SCON shares jumped 107.1% to $0.4079. Superconductor Technologies and Allied Integral United announced a merger agreement.
- NuCana plc NCNA shares climbed 38.9% to $8.02.
- Omeros Corporation OMER shares climbed 38.6% to $17.45 after the company reported Narsoplimab HSCT-TMA results surpassed the FDA-agreed efficacy threshold. The company also reported upbeat quarterly sales.
- Digirad Corporation DRAD shares rose 37.5% to $3.37.
- GenMark Diagnostics, Inc. GNMK gained 28.8% to $4.52 after the company reported Q4 earnings results.
- Capstone Turbine Corporation CPST surged 20% to $2.54.
- KemPharm, Inc. KMPH rose 16.2% to $0.38 after the company submitted KP415 NDA to the FDA for the treatment of ADHD.
- Boingo Wireless Inc WIFI rose 15.5% to $13.74 after the company reported Q4 earnings.
- Inovio Pharmaceuticals, Inc. INO gained 15.3% to $5.06. Inovio Pharmaceuticals announced an accelerated timeline Tuesday for the development of its INO-4800 vaccine targeting the COVID-19 virus. Inovio said it plans to have 1 million doses of the INO-4800 COVID-19 DNA vaccine produced by the end of 2020 either for an emergency or for further trials.
- Metalla Royalty & Streaming Ltd. MTA gained 15.1% to $5.40.
- Trillium Therapeutics Inc. TRIL rose 14.6% to $5.44 after surging over 26% on Monday.
- Alpha Pro Tech, Ltd. APT shares rose 14.6% to $18.33.
- QIAGEN N.V. QGEN shares rose 14.5% to $41.36. Thermo Fisher Scientific Inc. TMO announced plans to acquire QIAGEN for 10.4 billion euros ($11.6 billion).
- Gold Resource Corporation GORO gained 14.4% to $4.93 after the company updated its proven & probable reserves.
- DRDGOLD Limited DRD gained 13.4% to $7.36.
- Theratechnologies Inc. THTX climbed 13.2% to $2.74.
- Genworth Financial, Inc. GNW rose 12.8% to $4.7150 after the company and China Oceanwide Holdings reached an agreement in principle with the New York State Department of Financial Services on conditions expected to facilitate reapproval of merger.
- 500.com Limited WBAI surged 12% to $6.05.
- Homology Medicines, Inc. FIXX rose 11.8% to $19.00.
- Veeco Instruments Inc. VECO gained 11.7% to $15.04. Stifel Nicolaus upgraded Veeco Instruments from Hold to Buy and raised the price target from $14 to $18.
- AngloGold Ashanti Limited AU climbed 11.6% to $20.62.
- Autolus Therapeutics plc AUTL rose 9.9% to $9.23.
- Sterling Construction Company, Inc. STRL gained 9.5% to $14.87 following strong quarterly sales.
Check out these big penny stock gainers and losers
Losers
- China Pharma Holdings, Inc. CPHI fell 28.1% to $0.82. China Pharma shares jumped 100% on Monday after the company announced a wash-free sanitizer in response to the coronavirus.
- Ritter Pharmaceuticals, Inc. RTTR fell 27.6% to $0.4438 after slipping over 11% on Monday.
- Daxor Corporation DXR dropped 24.2% to $10.80. Daxor shares rose 65.7% on Monday after the company said hospitals are using its blood volume analyzer to prevent coronavirus deaths.
- InflaRx N.V. IFRX shares declined 23.2% to $4.67.
- Heat Biologics, Inc. HTBX fell 19.4% to $0.6450. Heat Biologics shares jumped more than 142% on Monday after the Durham, North, Carolina-based biopharma company said in an SEC filing that it has filed a provisional patent application that would apply its immune system activating technology for the treatment or prevention ofCOVID-19, the new coronavirus originating from Wuhan, China.
- Novan Inc NOVN fell 18.8% to $0.3794 after the company filed 14 million share common stock offering, including warrants.
- Vaxart, Inc. VXRT fell 18% to $1.92 after dropping more than 18% on Monday.
- OpGen, Inc. OPGN dipped 16.8% to $2.8386.
- BOQI International Medical Inc. BIMI tumbled 16.5% to $4.175.
- Altimmune, Inc. ALT shares fell 15.8% to $2.66 after declining about 15% on Monday.
- Precigen, Inc. PGEN dropped 15.3% to $3.31 after the company reported worse-than-expected Q4 sales results.
- iBio, Inc. IBIO shares dipped 15% to $1.88. iBio highlighted withdrawal of proxy statement proposal related to amend its certificate of incorporation to authorize possible reverse stock split.
- Tilray, Inc. TLRY fell 14.1% to $13.19. Tilray reported a net loss of $219.2 million, or $2.14 a share for the fourth quarter, versus a year-ago loss of $31 million or $0.33 per share. The company also reported worse-than-expected Q4 sales.
- Novavax, Inc. NVAX fell 13.7% to $10.37. Novavax shares tumbled around 25% on Monday following news of a $150 million common stock offering via B. Riley FBR.
- Vir Biotechnology, Inc. VIR fell 13.4% to $39.05.
- Titan International, Inc. TWI dipped 13.4% to $1.8350.
- Red Violet, Inc. RDVT shares declined 13.3% to $22.97.
- Co-Diagnostics, Inc. CODX fell 13.1% to $15.47. Co-Diagnostics shares gained around 35% on Monday after the company announced it will provide COVID-19 tests to US CLIA labs.
- GreenSky, Inc. GSKY dropped 12.7% to $6.87.
- Mallinckrodt plc MNK shares declined 11.4% to $3.7397.
- Nine Energy Service, Inc. NINE slipped 11.3% to $3.15.
- FlexShopper, Inc. FPAY shares fell 10% to $2.6016.
- Karyopharm Therapeutics Inc KPTI fell 9.9% to $24.97 after the company announced a proposed public offering of common stock of $150 million.
- OptimizeRx Corporation OPRX shares dipped 9.5% to $7.34.
- Axos Financial, Inc. AX fell 8.8% to $23.66.
- Cronos Group Inc. CRON dropped 8.8% to $5.49. Cronos Group said Monday it has submitted a Form 12b-25 with the U.S. Securities and Exchange Commission to postpone the date of filing its annual report for 15 days.
- Applied DNA Sciences, Inc. APDN shares fell 7.5% to $4.79 after rising around 30% on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsMoversTrading IdeasHealth CareMid-Day MoversPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in